Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Molecular magnetic resonance contrast agents for the detection of cancer: past and present.

Bogdanov A Jr, Mazzanti ML.

Semin Oncol. 2011 Feb;38(1):42-54. doi: 10.1053/j.seminoncol.2010.11.002. Review.

2.

Magnetic resonance in the era of molecular imaging of cancer.

Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE.

Magn Reson Imaging. 2011 Jun;29(5):587-600. doi: 10.1016/j.mri.2011.02.003. Epub 2011 Apr 27. Review.

3.

Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.

Misri R, Meier D, Yung AC, Kozlowski P, Häfeli UO.

Nanomedicine. 2012 Aug;8(6):1007-16. doi: 10.1016/j.nano.2011.10.013. Epub 2011 Nov 16.

PMID:
22100757
4.

Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.

Dassler K, Roohi F, Lohrke J, Ide A, Remmele S, Hütter J, Pietsch H, Pison U, Schütz G.

Invest Radiol. 2012 Jul;47(7):383-91. doi: 10.1097/RLI.0b013e31824c5a57.

PMID:
22659596
5.

Molecular imaging in cardiovascular diseases.

Botnar RM, Ebersberger H, Noerenberg D, Jansen CH, Wiethoff AJ, Schuster A, Kasner M, Walter TC, Knobloch G, Hoppe P, Diederichs G, Hamm B, Makowski MR.

Rofo. 2015 Feb;187(2):92-101. doi: 10.1055/s-0034-1385451. Epub 2015 Jan 13. Review.

6.

Developing MR probes for molecular imaging.

McMahon MT, Chan KW.

Adv Cancer Res. 2014;124:297-327. doi: 10.1016/B978-0-12-411638-2.00009-4. Review.

PMID:
25287693
7.

Glycoconjugate probes and targets for molecular imaging using magnetic resonance.

Geraldes CF, Djanashvili K, Peters JA.

Future Med Chem. 2010 Mar;2(3):409-25. doi: 10.4155/fmc.09.157. Review.

8.

Mono-dispersed high magnetic resonance sensitive magnetite nanocluster probe for detection of nascent tumors by magnetic resonance molecular imaging.

Zhang C, Xie X, Liang S, Li M, Liu Y, Gu H.

Nanomedicine. 2012 Aug;8(6):996-1006. doi: 10.1016/j.nano.2011.11.013. Epub 2011 Dec 23.

PMID:
22197723
9.

The medicinal chemistry of targeted tumor imaging (II).

Chen XS.

Curr Top Med Chem. 2010;10(12):1145-6. No abstract available.

PMID:
20681946
10.

Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspective.

Oghabian MA, Farahbakhsh NM.

J Biomed Nanotechnol. 2010 Jun;6(3):203-13. Review.

PMID:
21179937
11.

Molecular imaging with targeted contrast agents.

Makowski MR, Wiethoff AJ, Jansen CH, Botnar RM.

Top Magn Reson Imaging. 2009 Aug;20(4):247-59. doi: 10.1097/RMR.0b013e3181ea28b1. Review.

PMID:
20805735
12.

99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.

Xue S, Zhang C, Yang Y, Zhang L, Cheng D, Zhang J, Shi H, Zhang Y.

J Biomed Nanotechnol. 2015 Jun;11(6):1027-37.

PMID:
26353592
13.

Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.

Pais A, Biton IE, Margalit R, Degani H.

Magn Reson Med. 2013 Jul;70(1):193-206. doi: 10.1002/mrm.24442. Epub 2012 Aug 10.

14.

Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents.

Pu F, Xue S, Qiao J, Patel A, Yang JJ.

Curr Protein Pept Sci. 2016;17(6):519-33. Review.

PMID:
26721404
15.

An introduction to functional and molecular imaging with MRI.

Gallagher FA.

Clin Radiol. 2010 Jul;65(7):557-66. doi: 10.1016/j.crad.2010.04.006.

PMID:
20541655
16.

Chemistry of tumour targeted T1 based MRI contrast agents.

Kamaly N, Miller AD, Bell JD.

Curr Top Med Chem. 2010;10(12):1158-83. Review.

PMID:
20388110
17.

Imaging Tumor Metastases with Molecular Probes.

Qiao R, Zhu R, Gao M.

Curr Pharm Des. 2015;21(42):6260-4. Review.

PMID:
26503140
18.

New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.

Mustafi D, Peng B, Foxley S, Makinen MW, Karczmar GS, Zamora M, Ejnik J, Martin H.

J Biol Inorg Chem. 2009 Nov;14(8):1187-97. doi: 10.1007/s00775-009-0562-0. Epub 2009 Jul 2.

PMID:
19572156
19.

Multifunctional magnetic resonance imaging probes.

Kluza E, Strijkers GJ, Nicolay K.

Recent Results Cancer Res. 2013;187:151-90. doi: 10.1007/978-3-642-10853-2_5.

PMID:
23179881
20.

MR molecular imaging of tumor vasculature and vascular targets.

Pathak AP, Penet MF, Bhujwalla ZM.

Adv Genet. 2010;69:1-30. doi: 10.1016/S0065-2660(10)69010-4. Review.

Supplemental Content

Support Center